Inicio>>Signaling Pathways>> Others>>Muzolimine

Muzolimine (Synonyms: BAY-g 2821; Edrul)

Catalog No.GC69514

Muzolimine (BAY-g 282) es un diurético de acción lenta y prolongada. Muzolimine produce efectos diuréticos en el asa de Henle del riñón y tiene propiedades antihipertensivas. Muzolimine puede ser utilizado en la investigación de enfermedades cardiovasculares.

Products are for research use only. Not for human use. We do not sell to patients.

Muzolimine Chemical Structure

Cas No.: 55294-15-0

Tamaño Precio Disponibilidad Cantidad
5mg
135,00 $
Disponible
10mg
225,00 $
Disponible
25mg
495,00 $
Disponible
50mg
765,00 $
Disponible
100mg
1.215,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of Muzolimine

Cas No. 55294-15-0 SDF
Sinónimos BAY-g 2821; Edrul
Formula C11H11Cl2N3O M.Wt 272.13
Solubility DMSO : 100 mg/mL (367.47 mM; Need ultrasonic) Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Muzolimine

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 3.6747 mL 18.3736 mL 36.7471 mL
5 mM 0.7349 mL 3.6747 mL 7.3494 mL
10 mM 0.3675 mL 1.8374 mL 3.6747 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of Muzolimine

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reseñas

Review for Muzolimine

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Muzolimine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.